Nicholas Terry, Mctm
About Nicholas Terry, Mctm
Nicholas Terry is a Senior Executive Sales Professional specializing in psychology at Supernus Pharmaceuticals, Inc., where he has worked since 2014. He has a Master's degree in Clinical Translation Management and has successfully launched three clinical therapies in the CNS space.
Work at Supernus Pharmaceuticals
Nicholas Terry has been employed at Supernus Pharmaceuticals, Inc. since 2014. He holds the position of Senior Executive Sales Professional in the Psychology division and serves as an Executive Sales Representative in the Neurology division. Over his tenure of 10 years in the Houston, Texas area, he has successfully launched three new clinical therapies within the CNS clinical space: Trokendi XR, Oxtellar XR, and Qelbree. His role involves building relationships with clinical physicians and contributing to the company's market presence.
Education and Expertise
Nicholas Terry earned a Master's Degree in Clinical Translation Management from the University of St. Thomas (TX), completing his studies from 2019 to 2020. He also holds a Bachelor of Business Administration with a minor in Finance from The University of Texas at San Antonio, where he studied from 2006 to 2011. His educational background supports his expertise in sales and management within the pharmaceutical industry.
Background in Sales and Management
Before joining Supernus Pharmaceuticals, Nicholas Terry worked in various roles that contributed to his sales and management skills. He served as a Construction Manager at Meritage Homes for 11 months in 2010-2011 in the San Antonio, Texas area. He also participated in the Business Sales Leadership Development Program at AT&T and later worked as an Enterprise Account Manager from 2012 to 2014. These experiences provided him with a strong foundation in business operations and client relationship management.
Achievements in Sales Performance
Nicholas Terry has demonstrated strong sales performance throughout his career. He ranked 17th out of 191 in Territory Market Share for Qelbree in 2021 and improved his ranking to 16th out of 243 in 2023. He received the 2022 Who’s SFT50 Championship Award and achieved the 2024 Special Incentive Sales Representative for Market Share Growth in Q1. These accomplishments reflect his effectiveness in driving sales and expanding market share.